LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -13.83%2.7M | -85.30%1.79M | -81.28%552K | 70.42%16.81M | -45.22%-1.44M | -67.04%3.13M | 1,064.88%12.17M | 841.85%2.95M | 10.64%9.86M | -108.23%-993K |
Net income from continuing operations | 1,089.19%2.2M | -52.21%896K | -65.76%430K | -75.54%3.4M | -51.20%486K | -116.34%-222K | -34.35%1.88M | -85.51%1.26M | 53.57%13.88M | -62.56%996K |
Operating gains losses | -91.13%90K | -49.10%199K | -18.98%239K | 50.89%1.77M | -94.81%72K | 1,912.50%1.02M | 250.38%391K | 186.41%295K | 583.14%1.18M | 3,404.76%1.39M |
Depreciation and amortization | -37.39%849K | -53.98%902K | -39.53%1.03M | 9.81%6.26M | -39.59%1.25M | 4.07%1.36M | 95.02%1.96M | 27.64%1.7M | 50.08%5.7M | 87.53%2.06M |
Deferred tax | -314.89%-101K | -190.36%-75K | -37.70%-84K | -1,942.86%-1.57M | -322.11%-1.64M | -80.42%47K | -36.15%83K | -5.17%-61K | 66.08%-77K | ---389K |
Other non cash items | ---- | ---- | -200.00%-37K | ---- | ---- | ---- | ---- | --37K | ---55K | ---- |
Change In working capital | -165.24%-610K | -107.68%-595K | -331.02%-1.18M | 162.09%6.81M | 68.22%-1.6M | -85.95%935K | 373.31%7.75M | 97.19%-274K | -162.12%-10.97M | -159.50%-5.04M |
-Change in receivables | -194.89%-223K | -86.18%1.09M | 17.55%-653K | 174.08%5.68M | 69.27%-1.66M | -97.20%235K | 283.22%7.9M | 93.77%-792K | -236.98%-7.67M | -163.33%-5.41M |
-Change in payables and accrued expense | 209.35%860K | -146.42%-253K | 125.93%147K | -93.50%40K | 19.10%-216K | -8.85%278K | 131.80%545K | -124.75%-567K | -5.09%615K | 74.33%-267K |
-Change in other current assets | 41.81%-977K | -65.12%-497K | -205.61%-226K | 59.07%-729K | 17.84%1.04M | 3.34%-1.68M | -182.69%-301K | 116.61%214K | -125.16%-1.78M | 321.05%880K |
-Change in other current liabilities | -2.38%82K | -176.47%-893K | 9.32%305K | 163.56%806K | 454.63%766K | 137.33%84K | 91.68%-323K | -90.86%279K | 55.80%-1.27M | -764.00%-216K |
-Change in other working capital | -117.45%-352K | 38.89%-44K | -227.36%-754K | 217.21%1.01M | -4,147.22%-1.53M | 2,719.48%2.02M | -121.62%-72K | 154.81%592K | -177.83%-860K | -104.51%-36K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -13.83%2.7M | -85.30%1.79M | -81.28%552K | 70.42%16.81M | -45.22%-1.44M | -67.04%3.13M | 1,064.88%12.17M | 841.85%2.95M | 10.64%9.86M | -108.23%-993K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 26.59%-1.06M | 53.11%-1.14M | -11.17%-1.78M | 51.02%-6.61M | 78.01%-1.13M | 46.47%-1.45M | 18.23%-2.43M | 40.27%-1.6M | -68.72%-13.48M | -75.71%-5.13M |
Net PPE purchase and sale | -17.79%-980K | 51.36%-1.16M | 2.15%-1.59M | 39.95%-5.25M | 66.75%-400K | 53.05%-832K | 21.10%-2.39M | 40.52%-1.63M | -61.01%-8.74M | 45.12%-1.2M |
Net investment purchase and sale | 33.50%-135K | 71.13%-28K | -31.03%-38K | 81.65%-912K | 85.36%-583K | 79.45%-203K | ---97K | ---29K | -176.06%-4.97M | -397.63%-3.98M |
Net other investing changes | 112.59%52K | -9.09%50K | -372.73%-150K | -303.64%-448K | -363.64%-145K | -850.91%-413K | 0.00%55K | 0.00%55K | 159.95%220K | -24.66%55K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 26.59%-1.06M | 53.11%-1.14M | -11.17%-1.78M | 51.02%-6.61M | 78.01%-1.13M | 46.47%-1.45M | 18.23%-2.43M | 40.27%-1.6M | -68.72%-13.48M | -75.71%-5.13M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -57.12%-1.71M | -371.53%-2.07M | -1.63M | 31.53%-3.65M | -625.26%-2.13M | 20.10%-1.09M | 67.41%-439K | 0 | 44.32%-5.34M | 31.38%-293K |
Net common stock issuance | -57.12%-1.71M | -371.53%-2.07M | ---1.63M | 31.53%-3.65M | -625.26%-2.13M | 20.10%-1.09M | 67.41%-439K | --0 | 44.93%-5.34M | 31.38%-293K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -57.12%-1.71M | -371.53%-2.07M | ---1.63M | 31.53%-3.65M | -625.26%-2.13M | 20.10%-1.09M | 67.41%-439K | --0 | 44.32%-5.34M | 31.38%-293K |
Net cash flow | ||||||||||
Beginning cash position | -27.14%22.59M | 10.90%24.06M | 31.96%26.92M | -30.25%20.4M | 16.79%31.61M | 44.10%31.01M | -11.62%21.69M | -30.25%20.4M | -22.95%29.24M | 31.61%27.07M |
Current changes in cash | -112.79%-76K | -115.25%-1.42M | -312.48%-2.86M | 173.17%6.55M | 26.81%-4.7M | -89.06%594K | 384.62%9.31M | 128.63%1.35M | -3.43%-8.96M | -173.52%-6.42M |
Effect of exchange rate changes | -200.00%-15K | -900.00%-48K | 96.23%-2K | -130.00%-33K | 99.61%-1K | -87.60%15K | -97.52%6K | -5,400.00%-53K | 303.70%110K | -418.37%-254K |
End cash Position | -28.84%22.5M | -27.14%22.59M | 10.90%24.06M | 31.96%26.92M | 31.96%26.92M | 16.79%31.61M | 44.10%31.01M | -11.62%21.69M | -30.25%20.4M | -30.25%20.4M |
Free cash flow | -25.27%1.72M | -93.57%629K | -178.86%-1.04M | 924.36%11.57M | 16.12%-1.84M | -70.25%2.3M | 594.84%9.79M | 154.46%1.32M | -63.46%1.13M | -122.23%-2.2M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- |